The Asian Pacific Association for the Study of the Liver [APASL]

Hepatology International Online Free Subscription is available for all APASL members through the login page!

Abstract Deadline of STC Kumamoto extended until July 3!

Abstract Deadline of STC Kumamoto extended until July 3!

APASL STC 2026 Kumamoto (Sep. 18-19, 2026) will welcome an outstanding lineup of distinguished guests. We also hope you will take the opportunity to experience the unique charm of Kumamoto, from its rich culture and beautiful landscapes to its warm hospitality and local cuisine. Please take a look at the updated trailer to learn more about our guests and explore the many attractions of Kumamoto.  Further information of APASL STC 2026 Kumamoto is available at the following Website: https://www.apasl-stc2026kumamoto.org/ Conditions for Submission Abstract Categories Awards Excellent papers will be awarded as “Presidential Award”, “Investigator Award”, and “Travel Award”.

APASL 2027 Sydney Abstract Submission Now Open!

APASL 2027 Sydney Abstract Submission Now Open!

APASL 2027 ABSTRACT SUBMISSIONS NOW OPEN  Join APASL 2027 Sydney! APASL 2027 will be held on Australian soil and we’re excited to invite you to submit your abstract and showcase your research to the global liver and hepatology community. Abstract Submission options include: General Abstract Submissions Young Investigator Award (YIA) Abstract Submissions Abstracts submissions are encouraged across the following categories of clinical andbasic science: Submission information and detailed criteria is available HERE.Abstract submissions close 19th July, 23:59 AEST

AARC 2026 “Connect, Collaborate and Transform”

AARC 2026 “Connect, Collaborate and Transform”

AARC 2026 “Connect, Collaborate and Transform” was successfully held in a hybrid format during EASL 2026 in Barcelona. The meeting featured lively and productive discussions among participants, generating valuable insights and new perspectives for the future of ACLF research and collaboration. The strong engagement and exchange of ideas further reinforced the momentum for advancing the Consortium’s mission and activities. We sincerely thank all participants for their contributions and continued commitment. We look forward to your ongoing support and engagement in the APASL ACLF Research Consortium. APASL ACLF Research Consortium

ABSTRACT SUBMISSIONS NOW OPEN !! 

ABSTRACT SUBMISSIONS NOW OPEN !! 

APASL 2027 ABSTRACT SUBMISSIONS NOW OPEN  Join APASL 2027 Sydney!   APASL 2027 will be held on Australian soil and we’re excited to invite you to submit your abstract and showcase your research to the global liver and hepatology community. Abstract Submission options include: General Abstract Submissions There is no limit to how many general abstracts you may submit. Oral and Poster Presentation opportunities available. Young Investigator Award (YIA) Abstract Submissions One (1) abstract per applicant may be submitted for this award. Eighteen (18) finalists will present within a dedicated program session. One (1) Clinical Research and One (1) Basic Science winner will receive $2,000 AUD and Runners up $1,000 … [Read more]

APASL STC 2027 Kaohsiung will be held in June 2027!

APASL STC 2027 Kaohsiung will be held in June 2027!

Theme: MASLD/MAFLD Dates: June 2027 City: Kaohsiung, Taiwan President: Dr. Chia-Yen Dai   Harbor City, Kaohsiung Beyond the conference, you can enjoy Diversity Tour Experiences in Kaohsiung! Further information will be announced asap through APASL official Website, Newsletter and SNSs.

Hepatology International ARTICLES IN THE SPOTLIGHT : March-April 2026

Hepatology International ARTICLES IN THE SPOTLIGHT : March-April 2026

GUIDELINES: Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statementhttps://link.springer.com/article/10.1007/s12072-025-11023-x ORIGINAL ARTICLE: Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort studyhttps://link.springer.com/article/10.1007/s12072-025-11021-z ORIGINAL ARTICLE: TACE and tyrosine kinase inhibitors with or without PD-1 inhibitors as first-line therapy for intermediate-advanced HCC: a multicenter real-world cohort studyhttps://link.springer.com/article/10.1007/s12072-026-11052-0 ORIGINAL ARTICLE: Risk factors of adult recipient survival beyond 20 years since liver transplantation: retrospective cohort studyhttps://link.springer.com/article/10.1007/s12072-025-11029-5

APASL STC 2027 Chongqing

APASL STC 2027 Chongqing

Theme: Clinical Application of Liver Imaging in the AI Era Dates: 8–10 October 2027 City: Chongqing, China President: Dr. Jinjun Chen URL: To be announced *The host city has been changed from Guangzhou to Chongqing. Please save the dates!

APASL STC 2027 Danang, Vietnam will be held!

APASL STC 2027 Danang, Vietnam will be held!

APASL STC 2027 Danang Asian Pacific Association for the Study of Live Single Topic Conference From Chronic Liver Disease to HCC July 23-24, 2027 Novotel Danang Hotel, Danang, Vietnam Save the date!

APASL STC 2026 Dhaka will be held!

APASL STC 2026 Dhaka will be held!

APASL STC 2026 Dhaka Theme MAFLD: Evidence-based, Multidisciplinary Approach in the Era of Targeted Therapy Dates December 5-6, 2026 City Dhaka, Bangladesh President  Dr. Shahinul Alam URL To be announced.  

Already Registered ??

Already Registered ??

APASL Oncology 2026 Tokyo will be  held on April 2-3, 2026 !! Have you already registered for the conference ?? Please don’t forget to visit the following site for your smooth registration !!   https://www.apasl-oncology2026tokyo.org/reg.html

APASL 2026 Istanbul HIGHLIGHTS FROM THE SCIENTIFIC PROGRAM

APASL 2026 Istanbul HIGHLIGHTS FROM THE SCIENTIFIC PROGRAM

HIGHLIGHTS FROM THE SCIENTIFIC PROGRAM  ROLE OF IMAGING IN LIVER DISEASES Join us on Thursday, April 24th at 09:00 for the lectures by world-renown speakers and discussing further with them about the below topics: Evaluation of Liver Malignant Tumors with PET/MRI after Locoregional Treatment   Imaging Evaluation of Living Donor Candidates: Analysis of Liver Volume and Anatomy with CT  Impact of Liver Specific Contrast Agents in the Differential Diagnosis of Liver Masses Radiomics and Machine Learning  To view the entire congress program, please visit our congress website:👉 Program at a Glance We look forward to welcoming you in Istanbul. APASL 2026 IstanbulCongress Organizing Secretariat ✨ Stay ConnectedVisit our website and follow … [Read more]

APASL Oncology 2026 Tokyo Scientific Program updated!

APASL Oncology 2026 Tokyo Scientific Program updated!

Attention! The Scientific Program of the APASL Oncology 2026 Tokyo have been updated. Please check them out! https://www.apasl.info/wp-apasl/wp-content/uploads/2026/02/Scientific-Program-APASL-Oncology-2026-Tokyo-260214.pdfhttps://www.apasl.info/wp-apasl/wp-content/uploads/2026/02/Scientific-Program-APASL-Oncology-2026-Tokyo-260214.pdf Details of the free paper sessions will be announced soon. https://www.apasl-oncology2026tokyo.org/index.htmlhttps://www.apasl-oncology2026tokyo.org/index.html

Application Deadline for APASL Awards is Feb 15, 2026 !!

Application Deadline for APASL Awards is Feb 15, 2026 !!

We are delighted to remind that the application deadline for APASL Named Award and Rising Star Award is February 15, 2026 !!  There are only 3 days left, so apply now! Please check out the following details and get ready for your application !!   Named Awards 1) APASL Okuda-Omata Distinguished Award 2) APASL Powell-Sarin Achievement Award 3) APASL Lesmana-Sollano Great Mentor Award APASL will offer USD 5,000 for each.   <Selection Criteria for Named Awards> Presenters will be selected based upon the following criteria High original scientific research and achievements in a given area of liver diseases Continuous Contribution to APASL Activities Leadership role in academics and science in … [Read more]

Call for Abstracts of APASL-ONCOLOGY 2026 TOKYO!

Call for Abstracts of APASL-ONCOLOGY 2026 TOKYO!

APASL-ONCOLOGY 2026 TOKYO Abstract submission deadline has been extended until January 20, 2026 !  https://www.apasl.info/wp-apasl/wp-content/uploads/2026/01/f1d9ce63a105a76047a73f8c42cbbb96.mp4 Dear Colleagues, A Happy New Year! I hope this message finds you well, and I would like to extend my sincere best wishes to you for a successful and fulfilling year ahead. First of all, I would like to express my deepest appreciation for your continued dedication to APASL and its scientific activities. It is grateful to announce you the APASL-ONCOLOGY 2026 TOKYO will be held on April 2–3, 2026, at the University of Tokyo. And now we are calling for free papers. While we have received a strong number of abstracts to date, further … [Read more]

APASL 2026 Istanbul / Regarding Your Participation in Artificial Intelligence Studies

APASL 2026 Istanbul / Regarding Your Participation in Artificial Intelligence Studies

Subject: APASL 2026 Istanbul / Regarding Your Participation in Artificial Intelligence Studies AI BASED STU0DY LİNK https://forms.gle/4zvddwNak8J6ckeJ8   On behalf of the Organizing Committee of the 35th APASL Congress (APASL 2026 Istanbul), which will be held in Istanbul on 22–25 April 2026, we are honored to invite you to participate in four studies on Artificial Intelligence (AI) that will be conducted and subsequently presented at the congress.   Study 1 Topic: Can we predict the development of hepatocellular carcinoma (HCC) in the course of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma using artificial intelligence? Can an AI-mediated scoring system be developed to predict HCC development in these diseases? Study 2 … [Read more]

APASL STC 2026 Almaty will be held on October 8-9, 2026 !!

APASL STC 2026 Almaty will be held on October 8-9, 2026 !!

With the theme of ” Liver Diseases and Pregnancy “, APASL STC 2026 Almaty will be held on October 8-9, 2026 !! We are thrilled to welcome you all to the beautiful city of Almaty !! Please wait for the detailed information about abstract submission and registration !!